Eg. The United States Preventative Services Task Force (USPSTF) made a final recommendation on May 21, 2012 which aligned consistently with the draft recommendation publicly announced on October 7, 2011.
The recommendation is against prostate-specific antigen (PSA) based screening for healthy men, asserting that there is “moderate or high certainty that the service has no benefit or that the harms outweigh the benefits,”
VS -The American Urological Association, on the other hand, says the decision to undergo PSA testing should be individualized. Last year, the group criticized the USPSTF for doing "a great disservice by disparaging what is now the only widely available test for prostate cancer."
